Infor M3 for Pharmaceutical & Biotech Manufacturing

Pharmaceutical manufacturing operates under some of the strictest regulatory requirements of any industry. ERP systems must support GMP Annex 11 / 21 CFR Part 11 compliance, validated batch processing, full traceability, serialisation, and rigorous quality management — while also handling the commercial and supply chain complexities of global drug distribution.

Infor M3, available as Infor CloudSuite, provides process manufacturing capabilities that align well with pharmaceutical and biotech requirements. This guide covers what M3 delivers for pharma, where it excels, and how it compares to alternatives.

Evaluating ERP for pharma or biotech? Get independent pricing and partner recommendations.

Get Infor Pricing Compare Infor M3

---

Pharmaceutical Industry ERP Challenges

Pharma manufacturers face unique ERP requirements that generic systems struggle to address:

---

Infor M3 Capabilities for Pharma

GMP Annex 11 and 21 CFR Part 11 Compliance

EU GMP Annex 11 (retained in UK law post-Brexit) and FDA 21 CFR Part 11 both govern computerised systems and electronic records in regulated pharmaceutical environments. Infor M3 provides:

• Electronic signatures — Configurable e-signature capture for critical transactions (batch release, quality approvals, deviation closures)
• Audit trails — Immutable audit logs recording who changed what, when, and why across all regulated transactions
• Access controls — Role-based security with password policies, session management, and user authentication
• Data integrity — System-enforced data validation rules preventing unauthorised modification of batch records

Important: Regulatory compliance is not a software feature alone — it requires validation. Implementing M3 in a pharma environment includes IQ/OQ/PQ (Installation, Operational, and Performance Qualification) as part of the validation lifecycle. This adds significant time and cost to implementation but is non-negotiable for MHRA- or FDA-regulated facilities.

Batch Process Management

M3's batch manufacturing capabilities support pharmaceutical production workflows:

• Master batch records — Define production recipes with exact ingredient specifications, process parameters, and quality checkpoints
• Batch execution — Real-time recording of actual production data against the master batch record
• Yield tracking — Actual vs. theoretical yield tracking with automatic variance reporting
• Potency-based formulation — Adjust ingredient quantities based on API potency test results for each incoming lot
• Co-product and by-product management — Handle production outputs that generate multiple products from a single process
• Batch genealogy — Full forward and backward traceability linking API lots, excipient lots, intermediate products, and finished goods

Quality Management (GMP)

M3's quality module supports pharmaceutical GMP requirements:

Serialisation & Track-and-Trace

The pharmaceutical industry faces increasing serialisation mandates:

• UK Falsified Medicines Regulations — Requires serialisation and verification for prescription medicines sold in the UK; enforcement is managed by the MHRA
• EU Falsified Medicines Directive (FMD) — Requires serialisation and verification for prescription medicines across the EU
• FDA DSCSA — Requires unique product identifiers on pharmaceutical packages sold in the US (relevant for UK companies exporting to the American market; extended implementation deadlines apply)
• China, Brazil, others — Country-specific serialisation requirements

M3 provides the product data management foundation for serialisation and integrates with specialised serialisation solutions (TraceLink, SAP ATTP, Antares Vision) via Infor ION middleware. The integration handles:

• Serial number generation and assignment
• Aggregation (serial to case to pallet)
• Commissioning and decommissioning events
• Regulatory reporting to national verification systems

Shelf Life & Expiry Management

• Lot-level shelf life tracking with configurable date types (manufacturing date, expiry date, retest date)
• FEFO (First Expired, First Out) warehouse management
• Country-specific minimum remaining shelf life requirements
• Automatic quarantine of expired or near-expiry lots
• Stability-based shelf life extension workflows

---

Implementation Considerations for Pharma

Validation Requirements

Pharma implementations require a validated computing environment per GAMP 5 (Good Automated Manufacturing Practice) guidelines:

Validation adds 30–50% to the implementation timeline and 20–40% to the cost compared to a non-regulated implementation. This is unavoidable for MHRA- or FDA-regulated manufacturers.

Typical Costs for Pharma Manufacturers

Integration Requirements

Pharma facilities typically require integration between M3 and:

• LIMS (Laboratory Information Management System) — Quality test results and CoA data
• MES (Manufacturing Execution System) — Shop floor data collection and batch record execution
• Serialisation platforms (TraceLink, SAP ATTP) — Serial number management and regulatory reporting
• DMS (Document Management System) — SOPs, batch records, regulatory submissions
• Regulatory systems — MHRA submission tracking, market authorisation management

---

Infor M3 vs SAP for Pharmaceutical Manufacturing

Key takeaway: SAP S/4HANA offers broader functionality and a larger pharma-specialist partner ecosystem, which is important for very large pharmaceutical companies with complex global operations. Infor M3 provides strong process manufacturing depth at a lower cost point, making it a compelling choice for small-to-mid-market pharma and biotech companies where cost efficiency matters.

For contract manufacturing organisations (CMOs/CDMOs), M3's multi-company architecture and batch process management capabilities are particularly well-suited.

---

Frequently Asked Questions

Is Infor M3 validated for regulatory compliance?

Infor M3 is validatable — meaning the software provides the technical capabilities needed for GMP Annex 11 and 21 CFR Part 11 compliance (electronic signatures, audit trails, access controls). However, validation is the customer's responsibility. Each implementation must be validated through IQ/OQ/PQ per GAMP 5 guidelines, and that validation is specific to your configuration and processes.

Can Infor M3 handle pharmaceutical serialisation?

M3 does not include a native serialisation engine. It integrates with industry-leading serialisation platforms (TraceLink, SAP ATTP, Antares Vision) via Infor ION to manage serial number assignment, aggregation, and regulatory reporting. This integration approach is common across ERP vendors — only SAP offers a fully native serialisation module.

How does Infor M3 compare to dedicated pharma ERPs like BatchMaster?

BatchMaster offers deeper pharma-specific functionality (formulation, stability testing, regulatory submission management) for smaller organisations, but lacks M3's enterprise scalability and multi-country capabilities. M3 is the better choice for pharma companies with multi-site, multi-country operations or those planning significant growth. BatchMaster is better suited for single-site operations under £40M revenue.

What GAMP 5 software category is Infor M3?

Infor M3 is classified as a Category 4 (configured software) product under GAMP 5. This means it is a commercial-off-the-shelf system that requires configuration to meet specific business requirements. Validation effort focuses on verifying that the configured system meets user requirements (OQ/PQ), not validating the underlying software code.

---

Next Steps

Evaluating ERP for pharmaceutical manufacturing? Get independent pricing and connect with pharma-experienced implementation partners.

Get Infor Pricing Compare Infor M3

Related pages:

• Infor M3 Overview
• Infor M3 Costs
• Infor M3 for Food & Beverage
• Infor M3 for Chemicals
• Best ERP for Pharmaceuticals